ラウンドテーブルディスカッション 1
3月26日［金］10:00-11:30
|
| |
| |
The need for stronger LDL management in secondary prevention
|
|
|
| |
| |
|
|
| |
脂質低下療法は動脈硬化性疾患治療の基礎となる部分である。当セッションでは、冠動脈疾患二次予防におけるLDL管理に関して様々な角度から考察を加えたい。
|
|
|
| |
| |
|
|
| |
| |
 |
|
Junya Ako
Cardiovascular Medicine, Kitasato University, Sagamihara
|
|
 |
|
Marc S. Sabatine
Cardiovascular Medicine, TIMI Study Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
|
|
|
| |
| |
| |
| |
|
|
| |
| |
|
|
Marc S. Sabatine
Cardiovascular Medicine, TIMI Study Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
|
|
 |
|
Hiroshi Iwata
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo
|
|
|
| |
| |
 |
|
Kenichi Tsujita
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto
|
|
 |
|
Hayato Tada
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa
|
|
|
| |
| |
|
|